1Leung N. Liver disease-significant improvement with lamivudine. J Med Vir, 2000, 61: 380-385.
2Perrillo RP, Lai CL, Liaw YF, et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology, 2002,36: 186-194.
3Kweon YO, Goodman ZD, Dienstag JL, et al. Decreasing fibrogenesis:an immunohistochemincal study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Heptol, 2001, 35:749-755.
4Niesters HG,Honkoop P, Haagsma EB,et al. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J Infect Dis,1998,177 : 1382-1385.
5Blum HE. Hepatitis B virus: significance of naturally occurring mutants. Intervirology, 1993,35: 40-50.
6Liu CJ,Chen PJ,Lai MY, et al. Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full length viral sequences. Hepatology,2001,34:583-589.
7Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during longterm lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology, 1998,27:1711-1716.
8Serfaty L, Thabut D, Zoulim F, et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.Hepatology, 2001, 34:573-577.
9EASL Jury. EASL International Consensus Conference on Hepatitis B. J Hepatol, 2003, 38:533-540.
10Buti, M Esteban R. Entecavir, FTC, L-FMAU, LdT and others. J Hepatol, 2003, 39:S139-S142.
6[1]Doongs,Tsai C,SchinaZi R,et d.Inhibition of the replicatin of hepatitis B vires in vitro by 2'-3'-dideoxy-3'-Thicacytidine and related analogues[J].Proc Natl Acad Sci usA,1991,88:8495～8499.
7Brechtbuehl K,Whalley SA,Dusheiko GM,et al. A rapid real timequantitative polymerase chain reaction for hepatitis B virus [J].Virol Methods,2001,93(1) : 105-113.
8Ho SK, Yam WC,Leung ET,et al. Rapid quantification of hepati-tis B virus DNA by real-time PCR using fluorescent hybridizationprobes[J]. Med Microbiol,2003,52(5) :397-402.
9Kobayashi S.Ide T* Sata M. Detection of YMDD motif mutationsin some lamivudine-untreated asymptomatic hepatitis B virus car-riers[J]. J Hepatol,2001,34(4) : 584-586.
